Xenon Pharmaceuticals initiated with a Buy at Deutsche Bank
Deutsche Bank initiated coverage of Xenon Pharmaceuticals (XENE) with a Buy rating and $67 price target Maximize Your Portfolio with Data ...
Yahoo Finance3d
Xenon Outlines Key Corporate Milestone Opportunities for 2025
VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering ...